

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | indole-containing compound catabolic process (GO:0042436) | 4.90049599 |
| 2 | indolalkylamine catabolic process (GO:0046218) | 4.90049599 |
| 3 | tryptophan catabolic process (GO:0006569) | 4.90049599 |
| 4 | paraxial mesoderm development (GO:0048339) | 4.82963621 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 4.62147871 |
| 6 | tryptophan metabolic process (GO:0006568) | 4.59361566 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 4.55403523 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.55403523 |
| 9 | cellular biogenic amine catabolic process (GO:0042402) | 4.34057447 |
| 10 | amine catabolic process (GO:0009310) | 4.34057447 |
| 11 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.28780042 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 4.21028241 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.21028241 |
| 14 | bile acid biosynthetic process (GO:0006699) | 3.87375727 |
| 15 | kynurenine metabolic process (GO:0070189) | 3.83923520 |
| 16 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.82203942 |
| 17 | indolalkylamine metabolic process (GO:0006586) | 3.80251500 |
| 18 | negative regulation of hormone metabolic process (GO:0032351) | 3.74914348 |
| 19 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.68746668 |
| 20 | urea metabolic process (GO:0019627) | 3.62713367 |
| 21 | urea cycle (GO:0000050) | 3.62713367 |
| 22 | coenzyme catabolic process (GO:0009109) | 3.59084171 |
| 23 | protein K11-linked deubiquitination (GO:0035871) | 3.59064233 |
| 24 | NAD biosynthetic process (GO:0009435) | 3.50807291 |
| 25 | androgen biosynthetic process (GO:0006702) | 3.48429929 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 3.48068685 |
| 27 | aromatic amino acid family metabolic process (GO:0009072) | 3.46282973 |
| 28 | positive regulation of glycolytic process (GO:0045821) | 3.44398504 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 3.41990047 |
| 30 | regulation of cholesterol esterification (GO:0010872) | 3.34862113 |
| 31 | glucuronate metabolic process (GO:0019585) | 3.28532855 |
| 32 | uronic acid metabolic process (GO:0006063) | 3.28532855 |
| 33 | presynaptic membrane assembly (GO:0097105) | 3.25359891 |
| 34 | regulation of fibrinolysis (GO:0051917) | 3.19947178 |
| 35 | complement activation, alternative pathway (GO:0006957) | 3.15108736 |
| 36 | bile acid metabolic process (GO:0008206) | 3.12431646 |
| 37 | regulation of glucocorticoid metabolic process (GO:0031943) | 3.12326947 |
| 38 | regulation of protein activation cascade (GO:2000257) | 3.11879956 |
| 39 | glyoxylate metabolic process (GO:0046487) | 3.11456796 |
| 40 | aldehyde catabolic process (GO:0046185) | 3.10429561 |
| 41 | blood coagulation, intrinsic pathway (GO:0007597) | 3.08691699 |
| 42 | cellular response to vitamin (GO:0071295) | 3.07112243 |
| 43 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.06340175 |
| 44 | cellular response to vitamin D (GO:0071305) | 3.06221751 |
| 45 | cellular glucuronidation (GO:0052695) | 3.03268324 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.01235286 |
| 47 | metanephric mesenchyme development (GO:0072075) | 2.99411568 |
| 48 | type B pancreatic cell development (GO:0003323) | 2.97478231 |
| 49 | short-term memory (GO:0007614) | 2.96994913 |
| 50 | positive regulation of osteoblast proliferation (GO:0033690) | 2.96624849 |
| 51 | low-density lipoprotein particle remodeling (GO:0034374) | 2.95105189 |
| 52 | kidney mesenchyme development (GO:0072074) | 2.95103966 |
| 53 | regulation of complement activation (GO:0030449) | 2.94651497 |
| 54 | arginine catabolic process (GO:0006527) | 2.94263374 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 2.94111997 |
| 56 | nucleotide transmembrane transport (GO:1901679) | 2.93676455 |
| 57 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.92436000 |
| 58 | tyrosine metabolic process (GO:0006570) | 2.90665683 |
| 59 | activation of protein kinase B activity (GO:0032148) | 2.89867247 |
| 60 | fatty acid elongation (GO:0030497) | 2.88668550 |
| 61 | polyol transport (GO:0015791) | 2.88598254 |
| 62 | arginine metabolic process (GO:0006525) | 2.88574378 |
| 63 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.87822679 |
| 64 | bone trabecula formation (GO:0060346) | 2.84121584 |
| 65 | regulation of bile acid biosynthetic process (GO:0070857) | 2.83349963 |
| 66 | high-density lipoprotein particle remodeling (GO:0034375) | 2.81455165 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 2.81145561 |
| 68 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.80152158 |
| 69 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.80014540 |
| 70 | positive regulation of protein homodimerization activity (GO:0090073) | 2.79571083 |
| 71 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.79250644 |
| 72 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.79068458 |
| 73 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.79068458 |
| 74 | COPII vesicle coating (GO:0048208) | 2.78599617 |
| 75 | amino sugar catabolic process (GO:0046348) | 2.78561939 |
| 76 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.77470027 |
| 77 | bile acid and bile salt transport (GO:0015721) | 2.75553822 |
| 78 | phospholipid efflux (GO:0033700) | 2.74286918 |
| 79 | triglyceride homeostasis (GO:0070328) | 2.73168753 |
| 80 | acylglycerol homeostasis (GO:0055090) | 2.73168753 |
| 81 | regulation of triglyceride catabolic process (GO:0010896) | 2.71317598 |
| 82 | cell migration involved in heart development (GO:0060973) | 2.69443720 |
| 83 | N-acetylneuraminate metabolic process (GO:0006054) | 2.69014378 |
| 84 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.68724519 |
| 85 | indole-containing compound metabolic process (GO:0042430) | 2.68680143 |
| 86 | presynaptic membrane organization (GO:0097090) | 2.68294625 |
| 87 | receptor recycling (GO:0001881) | 2.67481953 |
| 88 | cofactor catabolic process (GO:0051187) | 2.66676096 |
| 89 | negative regulation of lipase activity (GO:0060192) | 2.66408856 |
| 90 | androgen metabolic process (GO:0008209) | 2.66281709 |
| 91 | cytolysis (GO:0019835) | 2.65885068 |
| 92 | dermatan sulfate biosynthetic process (GO:0030208) | 2.65600208 |
| 93 | collagen fibril organization (GO:0030199) | 2.65184536 |
| 94 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.64902863 |
| 95 | protein carboxylation (GO:0018214) | 2.64351492 |
| 96 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.64351492 |
| 97 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.62142717 |
| 98 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.61026512 |
| 99 | response to hepatocyte growth factor (GO:0035728) | 2.61026512 |
| 100 | skin morphogenesis (GO:0043589) | 2.60798022 |
| 101 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.60758486 |
| 102 | chondrocyte proliferation (GO:0035988) | 2.60537330 |
| 103 | melanin metabolic process (GO:0006582) | 2.59036239 |
| 104 | facial nerve structural organization (GO:0021612) | 2.58698997 |
| 105 | protein-lipid complex remodeling (GO:0034368) | 2.58316861 |
| 106 | macromolecular complex remodeling (GO:0034367) | 2.58316861 |
| 107 | plasma lipoprotein particle remodeling (GO:0034369) | 2.58316861 |
| 108 | cellular amino acid catabolic process (GO:0009063) | 2.58310346 |
| 109 | phenylpropanoid metabolic process (GO:0009698) | 2.56853079 |
| 110 | righting reflex (GO:0060013) | 2.56728183 |
| 111 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.56428323 |
| 112 | response to folic acid (GO:0051593) | 2.55667072 |
| 113 | cyclic nucleotide catabolic process (GO:0009214) | 2.54569934 |
| 114 | carboxylic acid catabolic process (GO:0046395) | 2.53821406 |
| 115 | organic acid catabolic process (GO:0016054) | 2.53821406 |
| 116 | reverse cholesterol transport (GO:0043691) | 2.53774103 |
| 117 | benzene-containing compound metabolic process (GO:0042537) | 2.52400799 |
| 118 | inner ear receptor cell development (GO:0060119) | 2.51421432 |
| 119 | very long-chain fatty acid metabolic process (GO:0000038) | 2.50968094 |
| 120 | regulation of timing of cell differentiation (GO:0048505) | 2.50903069 |
| 121 | daunorubicin metabolic process (GO:0044597) | 2.50702824 |
| 122 | polyketide metabolic process (GO:0030638) | 2.50702824 |
| 123 | doxorubicin metabolic process (GO:0044598) | 2.50702824 |
| 124 | positive regulation of protein autophosphorylation (GO:0031954) | 2.49993275 |
| 125 | protein activation cascade (GO:0072376) | 2.49442367 |
| 126 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.48510100 |
| 127 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.48385971 |
| 128 | cholesterol efflux (GO:0033344) | 2.47917587 |
| 129 | protein heterotrimerization (GO:0070208) | 2.47323452 |
| 130 | amino-acid betaine metabolic process (GO:0006577) | 2.47166963 |
| 131 | adenosine metabolic process (GO:0046085) | 2.45326973 |
| 132 | fatty acid homeostasis (GO:0055089) | 2.43598906 |
| 133 | respiratory chain complex IV assembly (GO:0008535) | 2.42470868 |
| 134 | negative regulation of protein activation cascade (GO:2000258) | 2.42323460 |
| 135 | cell differentiation involved in metanephros development (GO:0072202) | 2.41672857 |
| 136 | secondary metabolite biosynthetic process (GO:0044550) | 2.39862091 |
| 137 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.39327554 |
| 138 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.39327554 |
| 139 | midgut development (GO:0007494) | 2.38704661 |
| 140 | dermatan sulfate metabolic process (GO:0030205) | 2.37677143 |
| 141 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.36909989 |
| 142 | extracellular matrix assembly (GO:0085029) | 2.36885935 |
| 143 | cGMP-mediated signaling (GO:0019934) | 2.33508297 |
| 144 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.32207319 |
| 145 | lactate metabolic process (GO:0006089) | 2.29234277 |
| 146 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.26923989 |
| 147 | phospholipid translocation (GO:0045332) | 2.24147535 |
| 148 | lipid translocation (GO:0034204) | 2.24147535 |
| 149 | positive regulation of meiosis (GO:0045836) | 2.23967820 |
| 150 | serotonin receptor signaling pathway (GO:0007210) | 2.23771509 |
| 151 | type B pancreatic cell proliferation (GO:0044342) | 2.23604205 |
| 152 | myelination in peripheral nervous system (GO:0022011) | 2.23436778 |
| 153 | peripheral nervous system axon ensheathment (GO:0032292) | 2.23436778 |
| 154 | macroautophagy (GO:0016236) | 2.23391107 |
| 155 | heparan sulfate proteoglycan metabolic process (GO:0030201) | 2.23045077 |
| 156 | insulin secretion (GO:0030073) | 2.22288487 |
| 157 | chondrocyte development (GO:0002063) | 2.20962019 |
| 158 | lymphangiogenesis (GO:0001946) | 2.20605199 |
| 159 | glandular epithelial cell development (GO:0002068) | 2.20155301 |
| 160 | artery development (GO:0060840) | 2.19879101 |
| 161 | tonic smooth muscle contraction (GO:0014820) | 2.19400134 |
| 162 | regulation of autophagic vacuole assembly (GO:2000785) | 2.14426313 |
| 163 | photoreceptor cell differentiation (GO:0046530) | 2.14271207 |
| 164 | eye photoreceptor cell differentiation (GO:0001754) | 2.14271207 |
| 165 | endocrine pancreas development (GO:0031018) | 2.11069497 |
| 166 | establishment of protein localization to Golgi (GO:0072600) | 2.11063719 |
| 167 | urinary tract smooth muscle contraction (GO:0014848) | 2.10878844 |
| 168 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.10281878 |
| 169 | chemosensory behavior (GO:0007635) | 2.10156246 |
| 170 | protein localization to cell surface (GO:0034394) | 2.09388508 |
| 171 | smooth muscle cell differentiation (GO:0051145) | 2.08402315 |
| 172 | positive regulation of meiotic cell cycle (GO:0051446) | 2.08135966 |
| 173 | vascular smooth muscle contraction (GO:0014829) | 2.07907029 |
| 174 | cellular zinc ion homeostasis (GO:0006882) | 2.07574930 |
| 175 | cardiac myofibril assembly (GO:0055003) | 2.07528675 |
| 176 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.07485335 |
| 177 | myofibril assembly (GO:0030239) | 2.06707089 |
| 178 | smooth muscle tissue development (GO:0048745) | 2.04641912 |
| 179 | regulation of osteoblast proliferation (GO:0033688) | 2.04594567 |
| 180 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.04575436 |
| 181 | melanin biosynthetic process (GO:0042438) | 2.04353131 |
| 182 | fibroblast migration (GO:0010761) | 2.04309709 |
| 183 | innervation (GO:0060384) | 2.03958029 |
| 184 | glomerular basement membrane development (GO:0032836) | 2.02393144 |
| 185 | negative regulation of bone remodeling (GO:0046851) | 2.01627825 |
| 186 | regulation of hormone biosynthetic process (GO:0046885) | 2.01416255 |
| 187 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.01201439 |
| 188 | anterior/posterior axis specification, embryo (GO:0008595) | 2.00904515 |
| 189 | cyclic-nucleotide-mediated signaling (GO:0019935) | 1.99284092 |
| 190 | regulation of protein glycosylation (GO:0060049) | 1.98967532 |
| 191 | sequestering of extracellular ligand from receptor (GO:0035581) | 1.98382167 |
| 192 | carnitine metabolic process (GO:0009437) | 1.97291326 |
| 193 | detection of calcium ion (GO:0005513) | 1.97153045 |
| 194 | regulation of appetite (GO:0032098) | 1.97076285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.77574581 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.54720665 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.45423802 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.99857927 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.84890287 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.53753776 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.52538924 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.40019878 |
| 9 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.38582198 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.30029714 |
| 11 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.28960362 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.28005498 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.27878108 |
| 14 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.18435866 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.13215260 |
| 16 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.10128318 |
| 17 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.02939814 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.01742876 |
| 19 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.98126497 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.89116114 |
| 21 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.86915007 |
| 22 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.85675908 |
| 23 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.83954412 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.82962139 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.80016890 |
| 26 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.78303324 |
| 27 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.78149471 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.78020264 |
| 29 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.76419988 |
| 30 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.76096605 |
| 31 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.76026745 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.71814042 |
| 33 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.69589793 |
| 34 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.68685068 |
| 35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.68039773 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.67288087 |
| 37 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.65421895 |
| 38 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.64890389 |
| 39 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.64342996 |
| 40 | AR_25329375_ChIP-Seq_VCAP_Human | 1.64323894 |
| 41 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.63389525 |
| 42 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.63368189 |
| 43 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.62919929 |
| 44 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.60728644 |
| 45 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.59902450 |
| 46 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.59286492 |
| 47 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.58613708 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.58365842 |
| 49 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.58319452 |
| 50 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.57351481 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.56578553 |
| 52 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55921155 |
| 53 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.55516399 |
| 54 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.54968023 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.54846090 |
| 56 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.54685868 |
| 57 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.54597691 |
| 58 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.52984375 |
| 59 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.51792586 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50987274 |
| 61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49857793 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.49015765 |
| 63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.49015765 |
| 64 | VDR_22108803_ChIP-Seq_LS180_Human | 1.47649857 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.47015220 |
| 66 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.45063627 |
| 67 | CJUN_26792858_Chip-Seq_BT549_Human | 1.43639852 |
| 68 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.41573949 |
| 69 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.41264243 |
| 70 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.40492998 |
| 71 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.40214376 |
| 72 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.39655110 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39593710 |
| 74 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.38774395 |
| 75 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.38547801 |
| 76 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.38523773 |
| 77 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.38489789 |
| 78 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.38489789 |
| 79 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.38168923 |
| 80 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.37302192 |
| 81 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.37281819 |
| 82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.36794168 |
| 83 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.36785293 |
| 84 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.36207709 |
| 85 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.35890094 |
| 86 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.34735704 |
| 87 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32950405 |
| 88 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32936409 |
| 89 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32512400 |
| 90 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.32208952 |
| 91 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31154289 |
| 92 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.29687362 |
| 93 | EWS_26573619_Chip-Seq_HEK293_Human | 1.29597671 |
| 94 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.29525505 |
| 95 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.28389166 |
| 96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27883734 |
| 97 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27876771 |
| 98 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.27512245 |
| 99 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.27284995 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27203702 |
| 101 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.25931432 |
| 102 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25705171 |
| 103 | TCF4_23295773_ChIP-Seq_U87_Human | 1.25515863 |
| 104 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.25197650 |
| 105 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25150239 |
| 106 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.25044471 |
| 107 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24939941 |
| 108 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24853237 |
| 109 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.23906534 |
| 110 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23734816 |
| 111 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22398636 |
| 112 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22149513 |
| 113 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.21146110 |
| 114 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.21139227 |
| 115 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.20530605 |
| 116 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.19235607 |
| 117 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.18735649 |
| 118 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.17226731 |
| 119 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.17053578 |
| 120 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14711594 |
| 121 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14009329 |
| 122 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13647414 |
| 123 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.13308302 |
| 124 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12991376 |
| 125 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.12926374 |
| 126 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.12211240 |
| 127 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11044282 |
| 128 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.10286045 |
| 129 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10239350 |
| 130 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.10082625 |
| 131 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09459969 |
| 132 | KDM2B_26808549_Chip-Seq_REH_Human | 1.09215678 |
| 133 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.06700980 |
| 134 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06003000 |
| 135 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05631096 |
| 136 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.04456333 |
| 137 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.04271351 |
| 138 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04200711 |
| 139 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03116263 |
| 140 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03080190 |
| 141 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.02631207 |
| 142 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.01717561 |
| 143 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.01188537 |
| 144 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01036046 |
| 145 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00366974 |
| 146 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00366974 |
| 147 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00130741 |
| 148 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99942543 |
| 149 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99802279 |
| 150 | AR_19668381_ChIP-Seq_PC3_Human | 0.98007182 |
| 151 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97888957 |
| 152 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.97555688 |
| 153 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.97459613 |
| 154 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.97216448 |
| 155 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.97140103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.49599060 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.49454864 |
| 3 | MP0003136_yellow_coat_color | 4.15294832 |
| 4 | MP0005360_urolithiasis | 3.97340517 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.94564866 |
| 6 | MP0003283_abnormal_digestive_organ | 3.72000963 |
| 7 | MP0000566_synostosis | 3.48165778 |
| 8 | MP0004381_abnormal_hair_follicle | 3.46009191 |
| 9 | MP0005503_abnormal_tendon_morphology | 3.40311534 |
| 10 | MP0006292_abnormal_olfactory_placode | 3.23273694 |
| 11 | MP0005365_abnormal_bile_salt | 3.18977623 |
| 12 | MP0001188_hyperpigmentation | 3.12520242 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.84792507 |
| 14 | MP0005409_darkened_coat_color | 2.80593321 |
| 15 | MP0004272_abnormal_basement_membrane | 2.74463857 |
| 16 | MP0009697_abnormal_copulation | 2.59205585 |
| 17 | MP0005257_abnormal_intraocular_pressure | 2.47388924 |
| 18 | MP0003252_abnormal_bile_duct | 2.39618881 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 2.36067031 |
| 20 | MP0003011_delayed_dark_adaptation | 2.35590933 |
| 21 | MP0002876_abnormal_thyroid_physiology | 2.32730982 |
| 22 | MP0009379_abnormal_foot_pigmentation | 2.30707871 |
| 23 | MP0003195_calcinosis | 2.23753203 |
| 24 | MP0005275_abnormal_skin_tensile | 2.20594285 |
| 25 | MP0000462_abnormal_digestive_system | 2.16039952 |
| 26 | MP0001986_abnormal_taste_sensitivity | 2.06116278 |
| 27 | MP0001299_abnormal_eye_distance/ | 2.05037574 |
| 28 | MP0003279_aneurysm | 2.03624846 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.95989384 |
| 30 | MP0003941_abnormal_skin_development | 1.88916261 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.88683916 |
| 32 | MP0005084_abnormal_gallbladder_morpholo | 1.84982363 |
| 33 | MP0000372_irregular_coat_pigmentation | 1.84030753 |
| 34 | MP0008260_abnormal_autophagy | 1.82254024 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.81986527 |
| 36 | MP0005171_absent_coat_pigmentation | 1.77143435 |
| 37 | MP0001958_emphysema | 1.77019861 |
| 38 | MP0000015_abnormal_ear_pigmentation | 1.68581261 |
| 39 | MP0006054_spinal_hemorrhage | 1.68239133 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.67596756 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.64936290 |
| 42 | MP0004019_abnormal_vitamin_homeostasis | 1.64032902 |
| 43 | MP0003868_abnormal_feces_composition | 1.63887717 |
| 44 | MP0002295_abnormal_pulmonary_circulatio | 1.63125626 |
| 45 | MP0010234_abnormal_vibrissa_follicle | 1.61843182 |
| 46 | MP0005332_abnormal_amino_acid | 1.61662962 |
| 47 | MP0010329_abnormal_lipoprotein_level | 1.56166450 |
| 48 | MP0005075_abnormal_melanosome_morpholog | 1.55829148 |
| 49 | MP0002108_abnormal_muscle_morphology | 1.53423284 |
| 50 | MP0006276_abnormal_autonomic_nervous | 1.51490720 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 1.50258114 |
| 52 | MP0005623_abnormal_meninges_morphology | 1.49782030 |
| 53 | MP0005408_hypopigmentation | 1.43460330 |
| 54 | MP0004142_abnormal_muscle_tone | 1.41786013 |
| 55 | MP0001764_abnormal_homeostasis | 1.36434046 |
| 56 | MP0002090_abnormal_vision | 1.35928734 |
| 57 | MP0010368_abnormal_lymphatic_system | 1.35321339 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.35034299 |
| 59 | MP0005551_abnormal_eye_electrophysiolog | 1.33932082 |
| 60 | MP0003880_abnormal_central_pattern | 1.29788165 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.27788523 |
| 62 | MP0000534_abnormal_ureter_morphology | 1.27778492 |
| 63 | MP0001270_distended_abdomen | 1.26787425 |
| 64 | MP0003724_increased_susceptibility_to | 1.24784462 |
| 65 | MP0009250_abnormal_appendicular_skeleto | 1.19792922 |
| 66 | MP0003385_abnormal_body_wall | 1.17809472 |
| 67 | MP0001984_abnormal_olfaction | 1.16900866 |
| 68 | MP0002909_abnormal_adrenal_gland | 1.14919926 |
| 69 | MP0000428_abnormal_craniofacial_morphol | 1.14257409 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 1.14041848 |
| 71 | MP0005508_abnormal_skeleton_morphology | 1.13394991 |
| 72 | MP0009384_cardiac_valve_regurgitation | 1.12899265 |
| 73 | MP0001879_abnormal_lymphatic_vessel | 1.12444573 |
| 74 | MP0005647_abnormal_sex_gland | 1.12348365 |
| 75 | MP0001666_abnormal_nutrient_absorption | 1.11694015 |
| 76 | MP0001486_abnormal_startle_reflex | 1.08681496 |
| 77 | MP0004134_abnormal_chest_morphology | 1.07897656 |
| 78 | MP0000751_myopathy | 1.07634642 |
| 79 | MP0004859_abnormal_synaptic_plasticity | 1.06435612 |
| 80 | MP0002249_abnormal_larynx_morphology | 1.06331325 |
| 81 | MP0005670_abnormal_white_adipose | 1.06073804 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 1.04492216 |
| 83 | MP0005187_abnormal_penis_morphology | 1.03439976 |
| 84 | MP0002896_abnormal_bone_mineralization | 1.03276269 |
| 85 | MP0000026_abnormal_inner_ear | 1.02958341 |
| 86 | MP0003942_abnormal_urinary_system | 1.02727986 |
| 87 | MP0005451_abnormal_body_composition | 1.02562488 |
| 88 | MP0002132_abnormal_respiratory_system | 1.02160344 |
| 89 | MP0000749_muscle_degeneration | 1.01947844 |
| 90 | MP0004742_abnormal_vestibular_system | 1.00959010 |
| 91 | MP0004270_analgesia | 1.00599008 |
| 92 | MP0001944_abnormal_pancreas_morphology | 0.98692517 |
| 93 | MP0002254_reproductive_system_inflammat | 0.98540050 |
| 94 | MP0002118_abnormal_lipid_homeostasis | 0.97194919 |
| 95 | MP0009046_muscle_twitch | 0.96793074 |
| 96 | MP0009764_decreased_sensitivity_to | 0.96356387 |
| 97 | MP0003718_maternal_effect | 0.95759469 |
| 98 | MP0002102_abnormal_ear_morphology | 0.95736809 |
| 99 | MP0000013_abnormal_adipose_tissue | 0.95728071 |
| 100 | MP0000371_diluted_coat_color | 0.94664138 |
| 101 | MP0010030_abnormal_orbit_morphology | 0.94662220 |
| 102 | MP0002277_abnormal_respiratory_mucosa | 0.94433363 |
| 103 | MP0002735_abnormal_chemical_nociception | 0.91783516 |
| 104 | MP0000432_abnormal_head_morphology | 0.90988510 |
| 105 | MP0000579_abnormal_nail_morphology | 0.90415454 |
| 106 | MP0003091_abnormal_cell_migration | 0.90039594 |
| 107 | MP0008004_abnormal_stomach_pH | 0.89293431 |
| 108 | MP0002269_muscular_atrophy | 0.88645399 |
| 109 | MP0005174_abnormal_tail_pigmentation | 0.87914922 |
| 110 | MP0000613_abnormal_salivary_gland | 0.86794902 |
| 111 | MP0004036_abnormal_muscle_relaxation | 0.86524443 |
| 112 | MP0000778_abnormal_nervous_system | 0.84706090 |
| 113 | MP0003950_abnormal_plasma_membrane | 0.83809418 |
| 114 | MP0002938_white_spotting | 0.83464771 |
| 115 | MP0000538_abnormal_urinary_bladder | 0.81985713 |
| 116 | MP0005083_abnormal_biliary_tract | 0.81768409 |
| 117 | MP0001968_abnormal_touch/_nociception | 0.81407408 |
| 118 | MP0001502_abnormal_circadian_rhythm | 0.81275085 |
| 119 | MP0002009_preneoplasia | 0.80936655 |
| 120 | MP0003755_abnormal_palate_morphology | 0.79135531 |
| 121 | MP0005535_abnormal_body_temperature | 0.79096684 |
| 122 | MP0004885_abnormal_endolymph | 0.78581163 |
| 123 | MP0000767_abnormal_smooth_muscle | 0.78577944 |
| 124 | MP0002837_dystrophic_cardiac_calcinosis | 0.77616171 |
| 125 | MP0000759_abnormal_skeletal_muscle | 0.77553892 |
| 126 | MP0003632_abnormal_nervous_system | 0.77376240 |
| 127 | MP0001905_abnormal_dopamine_level | 0.77368675 |
| 128 | MP0001542_abnormal_bone_strength | 0.76812052 |
| 129 | MP0002067_abnormal_sensory_capabilities | 0.76673708 |
| 130 | MP0001756_abnormal_urination | 0.76414377 |
| 131 | MP0003634_abnormal_glial_cell | 0.76097625 |
| 132 | MP0003633_abnormal_nervous_system | 0.76064622 |
| 133 | MP0002928_abnormal_bile_duct | 0.75771077 |
| 134 | MP0001324_abnormal_eye_pigmentation | 0.75165809 |
| 135 | MP0002168_other_aberrant_phenotype | 0.75075235 |
| 136 | MP0003646_muscle_fatigue | 0.74811964 |
| 137 | MP0003935_abnormal_craniofacial_develop | 0.73904367 |
| 138 | MP0001963_abnormal_hearing_physiology | 0.73814029 |
| 139 | MP0002272_abnormal_nervous_system | 0.73206316 |
| 140 | MP0001919_abnormal_reproductive_system | 0.72762802 |
| 141 | MP0002734_abnormal_mechanical_nocicepti | 0.72715705 |
| 142 | MP0000163_abnormal_cartilage_morphology | 0.72708523 |
| 143 | MP0002075_abnormal_coat/hair_pigmentati | 0.72375674 |
| 144 | MP0002557_abnormal_social/conspecific_i | 0.71654890 |
| 145 | MP0003937_abnormal_limbs/digits/tail_de | 0.71103866 |
| 146 | MP0000747_muscle_weakness | 0.71059643 |
| 147 | MP0003045_fibrosis | 0.70551111 |
| 148 | MP0003938_abnormal_ear_development | 0.69010454 |
| 149 | MP0005197_abnormal_uvea_morphology | 0.68924364 |
| 150 | MP0002751_abnormal_autonomic_nervous | 0.68677518 |
| 151 | MP0002233_abnormal_nose_morphology | 0.68635870 |
| 152 | MP0004782_abnormal_surfactant_physiolog | 0.68303153 |
| 153 | MP0002160_abnormal_reproductive_system | 0.66877599 |
| 154 | MP0000762_abnormal_tongue_morphology | 0.66730133 |
| 155 | MP0008789_abnormal_olfactory_epithelium | 0.66112495 |
| 156 | MP0002095_abnormal_skin_pigmentation | 0.65809637 |
| 157 | MP0002064_seizures | 0.65192071 |
| 158 | MP0002060_abnormal_skin_morphology | 0.64713308 |
| 159 | MP0002115_abnormal_skeleton_extremities | 0.64504346 |
| 160 | MP0003635_abnormal_synaptic_transmissio | 0.64361059 |
| 161 | MP0002822_catalepsy | 0.63314381 |
| 162 | MP0003186_abnormal_redox_activity | 0.63118031 |
| 163 | MP0009840_abnormal_foam_cell | 0.62558073 |
| 164 | MP0000631_abnormal_neuroendocrine_gland | 0.62164016 |
| 165 | MP0005595_abnormal_vascular_smooth | 0.62145858 |
| 166 | MP0001664_abnormal_digestion | 0.62041878 |
| 167 | MP0002971_abnormal_brown_adipose | 0.61517558 |
| 168 | MP0000609_abnormal_liver_physiology | 0.60833706 |
| 169 | MP0010386_abnormal_urinary_bladder | 0.60775363 |
| 170 | MP0005253_abnormal_eye_physiology | 0.60645079 |
| 171 | MP0002177_abnormal_outer_ear | 0.59961573 |
| 172 | MP0002229_neurodegeneration | 0.58860583 |
| 173 | MP0002752_abnormal_somatic_nervous | 0.58786469 |
| 174 | MP0005248_abnormal_Harderian_gland | 0.57385719 |
| 175 | MP0001186_pigmentation_phenotype | 0.57016788 |
| 176 | MP0009745_abnormal_behavioral_response | 0.55576934 |
| 177 | MP0009765_abnormal_xenobiotic_induced | 0.55309788 |
| 178 | MP0002163_abnormal_gland_morphology | 0.54753907 |
| 179 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.53499525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.69250435 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 5.16555227 |
| 3 | Broad metatarsal (HP:0001783) | 4.84194102 |
| 4 | Protrusio acetabuli (HP:0003179) | 4.18938814 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.09960212 |
| 6 | Joint hemorrhage (HP:0005261) | 4.01753404 |
| 7 | Symptomatic seizures (HP:0011145) | 3.85620467 |
| 8 | Premature rupture of membranes (HP:0001788) | 3.83056900 |
| 9 | Conjugated hyperbilirubinemia (HP:0002908) | 3.80722698 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.63358044 |
| 11 | Hyperglycinemia (HP:0002154) | 3.61311226 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.58082728 |
| 13 | Aortic aneurysm (HP:0004942) | 3.54492023 |
| 14 | Abnormality of dentin (HP:0010299) | 3.41505656 |
| 15 | Renal cortical cysts (HP:0000803) | 3.33476745 |
| 16 | Vascular tortuosity (HP:0004948) | 3.33041830 |
| 17 | Large for gestational age (HP:0001520) | 3.22110880 |
| 18 | Hyperglycinuria (HP:0003108) | 3.16614537 |
| 19 | Enlarged penis (HP:0000040) | 3.12642946 |
| 20 | Hypothermia (HP:0002045) | 3.00101465 |
| 21 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.97285762 |
| 22 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.97285762 |
| 23 | Complement deficiency (HP:0004431) | 2.96332183 |
| 24 | Shallow orbits (HP:0000586) | 2.94392606 |
| 25 | Reduced antithrombin III activity (HP:0001976) | 2.93464480 |
| 26 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.92283953 |
| 27 | Abnormality of secondary sexual hair (HP:0009888) | 2.85599028 |
| 28 | Abnormality of the axillary hair (HP:0100134) | 2.85599028 |
| 29 | Bile duct proliferation (HP:0001408) | 2.84407796 |
| 30 | Abnormal biliary tract physiology (HP:0012439) | 2.84407796 |
| 31 | Renal Fanconi syndrome (HP:0001994) | 2.82677925 |
| 32 | 3-Methylglutaconic aciduria (HP:0003535) | 2.80713075 |
| 33 | Type I transferrin isoform profile (HP:0003642) | 2.77757473 |
| 34 | Ankle contracture (HP:0006466) | 2.75152646 |
| 35 | Arterial tortuosity (HP:0005116) | 2.74241345 |
| 36 | Optic disc pallor (HP:0000543) | 2.73505526 |
| 37 | Ketoacidosis (HP:0001993) | 2.72887428 |
| 38 | Wormian bones (HP:0002645) | 2.72810148 |
| 39 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.70923567 |
| 40 | Aortic dissection (HP:0002647) | 2.70469161 |
| 41 | Cerebral edema (HP:0002181) | 2.61745368 |
| 42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.59027218 |
| 43 | Abnormality of glycine metabolism (HP:0010895) | 2.59027218 |
| 44 | Hypoplasia of the fovea (HP:0007750) | 2.56953103 |
| 45 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.56953103 |
| 46 | Epidermoid cyst (HP:0200040) | 2.56653967 |
| 47 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.54871825 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 2.52904294 |
| 49 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.52619822 |
| 50 | Overgrowth (HP:0001548) | 2.49892606 |
| 51 | Hypoventilation (HP:0002791) | 2.49670274 |
| 52 | Hyperglycemia (HP:0003074) | 2.47599822 |
| 53 | Hepatoblastoma (HP:0002884) | 2.46462749 |
| 54 | White forelock (HP:0002211) | 2.45124568 |
| 55 | True hermaphroditism (HP:0010459) | 2.42586884 |
| 56 | Hepatic necrosis (HP:0002605) | 2.41561674 |
| 57 | Abnormality of renal resorption (HP:0011038) | 2.39891693 |
| 58 | Neonatal short-limb short stature (HP:0008921) | 2.39247296 |
| 59 | Acute necrotizing encephalopathy (HP:0006965) | 2.39233094 |
| 60 | Hydroxyprolinuria (HP:0003080) | 2.39119946 |
| 61 | Abnormality of proline metabolism (HP:0010907) | 2.39119946 |
| 62 | Dry hair (HP:0011359) | 2.37880627 |
| 63 | Mitochondrial inheritance (HP:0001427) | 2.37262134 |
| 64 | Coronal craniosynostosis (HP:0004440) | 2.35267823 |
| 65 | Deep venous thrombosis (HP:0002625) | 2.35065400 |
| 66 | Febrile seizures (HP:0002373) | 2.34937512 |
| 67 | Increased circulating renin level (HP:0000848) | 2.33974677 |
| 68 | Mitral stenosis (HP:0001718) | 2.32562969 |
| 69 | Microvesicular hepatic steatosis (HP:0001414) | 2.32531625 |
| 70 | Abnormality of methionine metabolism (HP:0010901) | 2.32518261 |
| 71 | Acute encephalopathy (HP:0006846) | 2.31883092 |
| 72 | Xanthomatosis (HP:0000991) | 2.31799116 |
| 73 | Patchy hypopigmentation of hair (HP:0011365) | 2.31282610 |
| 74 | Hepatocellular necrosis (HP:0001404) | 2.29991353 |
| 75 | Soft skin (HP:0000977) | 2.29054951 |
| 76 | Fat malabsorption (HP:0002630) | 2.28808993 |
| 77 | Hyperlipoproteinemia (HP:0010980) | 2.27905340 |
| 78 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.26410418 |
| 79 | Hypophosphatemic rickets (HP:0004912) | 2.24541566 |
| 80 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.24519100 |
| 81 | Epileptiform EEG discharges (HP:0011182) | 2.23999748 |
| 82 | Fair hair (HP:0002286) | 2.23689129 |
| 83 | Hypobetalipoproteinemia (HP:0003563) | 2.22930692 |
| 84 | Abnormal sex determination (HP:0012244) | 2.22639011 |
| 85 | Sex reversal (HP:0012245) | 2.22639011 |
| 86 | Decreased central vision (HP:0007663) | 2.22550642 |
| 87 | Delayed gross motor development (HP:0002194) | 2.19194950 |
| 88 | Lethargy (HP:0001254) | 2.17997573 |
| 89 | Increased hepatocellular lipid droplets (HP:0006565) | 2.17814658 |
| 90 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17749596 |
| 91 | Attenuation of retinal blood vessels (HP:0007843) | 2.15684941 |
| 92 | Lipid accumulation in hepatocytes (HP:0006561) | 2.14098173 |
| 93 | Abnormality of urine glucose concentration (HP:0011016) | 2.11930354 |
| 94 | Glycosuria (HP:0003076) | 2.11930354 |
| 95 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.10425391 |
| 96 | Vertebral compression fractures (HP:0002953) | 2.09703731 |
| 97 | Abnormality of the calf musculature (HP:0001430) | 2.09636636 |
| 98 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.07732120 |
| 99 | Type 1 muscle fiber predominance (HP:0003803) | 2.07376062 |
| 100 | Abnormality of the fovea (HP:0000493) | 2.06798970 |
| 101 | Spinal rigidity (HP:0003306) | 2.06541945 |
| 102 | Renal tubular dysfunction (HP:0000124) | 2.06172470 |
| 103 | Abnormality of complement system (HP:0005339) | 2.06153666 |
| 104 | Enlarged kidneys (HP:0000105) | 2.05909453 |
| 105 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.04955583 |
| 106 | Hyperphosphatemia (HP:0002905) | 2.04181981 |
| 107 | Genu recurvatum (HP:0002816) | 2.04115419 |
| 108 | Bladder diverticulum (HP:0000015) | 2.03634315 |
| 109 | Abnormal pancreas size (HP:0012094) | 2.03226806 |
| 110 | Action tremor (HP:0002345) | 2.02599134 |
| 111 | Thyroid-stimulating hormone excess (HP:0002925) | 2.02583671 |
| 112 | Chronic hepatic failure (HP:0100626) | 2.00798277 |
| 113 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.97671382 |
| 114 | Increased CSF lactate (HP:0002490) | 1.97132934 |
| 115 | Tubulointerstitial nephritis (HP:0001970) | 1.97083263 |
| 116 | Hypsarrhythmia (HP:0002521) | 1.96946718 |
| 117 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.96927610 |
| 118 | Alveolar cell carcinoma (HP:0006519) | 1.96074385 |
| 119 | Hyperextensible skin (HP:0000974) | 1.95267127 |
| 120 | Cardiovascular calcification (HP:0011915) | 1.94283142 |
| 121 | Hypoglycemic coma (HP:0001325) | 1.94217871 |
| 122 | Increased variability in muscle fiber diameter (HP:0003557) | 1.93492300 |
| 123 | Tetraparesis (HP:0002273) | 1.93217875 |
| 124 | Progressive external ophthalmoplegia (HP:0000590) | 1.93076416 |
| 125 | Hypoglycemic seizures (HP:0002173) | 1.92416788 |
| 126 | Abnormality of the metopic suture (HP:0005556) | 1.91559840 |
| 127 | Progressive macrocephaly (HP:0004481) | 1.90819173 |
| 128 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.90803779 |
| 129 | Optic nerve hypoplasia (HP:0000609) | 1.90397824 |
| 130 | Prominent metopic ridge (HP:0005487) | 1.90090754 |
| 131 | Male pseudohermaphroditism (HP:0000037) | 1.89889574 |
| 132 | Dyschromatopsia (HP:0007641) | 1.89503191 |
| 133 | Limb-girdle muscle weakness (HP:0003325) | 1.89333613 |
| 134 | Osteomalacia (HP:0002749) | 1.88249648 |
| 135 | Abnormality of the intrinsic pathway (HP:0010989) | 1.87954153 |
| 136 | Vascular calcification (HP:0004934) | 1.87862627 |
| 137 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.87581773 |
| 138 | Abnormality of the ischium (HP:0003174) | 1.87528205 |
| 139 | Generalized hypopigmentation of hair (HP:0011358) | 1.86825608 |
| 140 | Prolonged neonatal jaundice (HP:0006579) | 1.86693190 |
| 141 | Congenital stationary night blindness (HP:0007642) | 1.86116063 |
| 142 | Anomalous pulmonary venous return (HP:0010772) | 1.85972547 |
| 143 | Hypoplastic ischia (HP:0003175) | 1.85840201 |
| 144 | Generalized aminoaciduria (HP:0002909) | 1.85537300 |
| 145 | Bowel diverticulosis (HP:0005222) | 1.85106153 |
| 146 | Medial flaring of the eyebrow (HP:0010747) | 1.84456880 |
| 147 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.83281128 |
| 148 | Knee flexion contracture (HP:0006380) | 1.83128017 |
| 149 | Congenital hepatic fibrosis (HP:0002612) | 1.80309523 |
| 150 | Blue irides (HP:0000635) | 1.79835936 |
| 151 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.79744605 |
| 152 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.79407489 |
| 153 | Septo-optic dysplasia (HP:0100842) | 1.79403328 |
| 154 | Congenital sensorineural hearing impairment (HP:0008527) | 1.79399791 |
| 155 | Hyperammonemia (HP:0001987) | 1.79181448 |
| 156 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.78977633 |
| 157 | Dicarboxylic aciduria (HP:0003215) | 1.78977633 |
| 158 | Abnormality of the renal cortex (HP:0011035) | 1.78857588 |
| 159 | Cerebral palsy (HP:0100021) | 1.78105397 |
| 160 | Atrophic scars (HP:0001075) | 1.77247882 |
| 161 | Aortic regurgitation (HP:0001659) | 1.76005277 |
| 162 | Wide anterior fontanel (HP:0000260) | 1.75425122 |
| 163 | Hypoplasia of the iris (HP:0007676) | 1.74869994 |
| 164 | Thoracolumbar scoliosis (HP:0002944) | 1.71730914 |
| 165 | Biconcave vertebral bodies (HP:0004586) | 1.70564577 |
| 166 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.70064749 |
| 167 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.70064749 |
| 168 | Broad ribs (HP:0000885) | 1.69916501 |
| 169 | Heterochromia iridis (HP:0001100) | 1.69436625 |
| 170 | Calf muscle hypertrophy (HP:0008981) | 1.68921089 |
| 171 | Aortic valve stenosis (HP:0001650) | 1.66076765 |
| 172 | Partial duplication of the phalanx of hand (HP:0009999) | 1.64589646 |
| 173 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.64301479 |
| 174 | Congenital glaucoma (HP:0001087) | 1.63675274 |
| 175 | Hemiparesis (HP:0001269) | 1.62673467 |
| 176 | Follicular hyperkeratosis (HP:0007502) | 1.62166134 |
| 177 | Proximal amyotrophy (HP:0007126) | 1.62041710 |
| 178 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.61384951 |
| 179 | Osteolytic defects of the hand bones (HP:0009699) | 1.61384951 |
| 180 | Hypomagnesemia (HP:0002917) | 1.61258441 |
| 181 | Late onset (HP:0003584) | 1.58682453 |
| 182 | Turricephaly (HP:0000262) | 1.58475535 |
| 183 | Dilatation of the ascending aorta (HP:0005111) | 1.56675212 |
| 184 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.55411884 |
| 185 | Macroorchidism (HP:0000053) | 1.55331243 |
| 186 | Long toe (HP:0010511) | 1.54703283 |
| 187 | Type I diabetes mellitus (HP:0100651) | 1.54009138 |
| 188 | Frequent falls (HP:0002359) | 1.52989671 |
| 189 | Partial duplication of thumb phalanx (HP:0009944) | 1.52923702 |
| 190 | Subaortic stenosis (HP:0001682) | 1.51858952 |
| 191 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.51858952 |
| 192 | Short nail (HP:0001799) | 1.51730832 |
| 193 | Round face (HP:0000311) | 1.50532979 |
| 194 | Insulin resistance (HP:0000855) | 1.49991196 |
| 195 | Redundant skin (HP:0001582) | 1.49338155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.59973360 |
| 2 | FRK | 5.02890860 |
| 3 | IRAK3 | 3.12684889 |
| 4 | FGFR2 | 2.97974057 |
| 5 | INSRR | 2.86451505 |
| 6 | MKNK2 | 2.76850606 |
| 7 | PRPF4B | 2.76570888 |
| 8 | TNIK | 2.70662525 |
| 9 | PNCK | 2.70242616 |
| 10 | PASK | 2.65788021 |
| 11 | LATS1 | 2.36054264 |
| 12 | ZAK | 2.31808633 |
| 13 | NTRK3 | 2.26091560 |
| 14 | PDGFRA | 2.15548011 |
| 15 | TLK1 | 2.07499552 |
| 16 | AKT3 | 2.05005320 |
| 17 | IRAK4 | 1.97737357 |
| 18 | MUSK | 1.97247722 |
| 19 | CAMK1G | 1.97128287 |
| 20 | MAP2K7 | 1.91918704 |
| 21 | MAPK13 | 1.91000812 |
| 22 | DDR2 | 1.82438979 |
| 23 | NME2 | 1.81486006 |
| 24 | STK16 | 1.74354360 |
| 25 | GRK1 | 1.71590058 |
| 26 | IRAK2 | 1.64815430 |
| 27 | IRAK1 | 1.61444276 |
| 28 | MAP3K2 | 1.60515126 |
| 29 | TXK | 1.53861562 |
| 30 | WNK3 | 1.48923714 |
| 31 | TRPM7 | 1.47841571 |
| 32 | SGK2 | 1.46754720 |
| 33 | BMPR2 | 1.46503564 |
| 34 | PINK1 | 1.40272590 |
| 35 | MKNK1 | 1.37616109 |
| 36 | LATS2 | 1.36723618 |
| 37 | SRPK1 | 1.35628553 |
| 38 | YES1 | 1.34781280 |
| 39 | NEK6 | 1.34169503 |
| 40 | MAP3K14 | 1.31520346 |
| 41 | PRKD3 | 1.29823957 |
| 42 | CDK3 | 1.26471855 |
| 43 | EIF2AK2 | 1.25883186 |
| 44 | BMPR1B | 1.24343487 |
| 45 | NLK | 1.23767933 |
| 46 | PAK3 | 1.22463226 |
| 47 | BCKDK | 1.22088042 |
| 48 | ADRBK2 | 1.21479200 |
| 49 | CSNK1A1L | 1.19264517 |
| 50 | ERBB4 | 1.17589989 |
| 51 | SGK494 | 1.14201021 |
| 52 | SGK223 | 1.14201021 |
| 53 | STK38L | 1.13217257 |
| 54 | MAPK15 | 1.12925588 |
| 55 | TNK2 | 1.11457429 |
| 56 | CSNK1G2 | 1.10284707 |
| 57 | PAK2 | 1.10089641 |
| 58 | PKN1 | 1.09154712 |
| 59 | CAMK1D | 1.07902265 |
| 60 | PDGFRB | 1.07494054 |
| 61 | LIMK1 | 1.05632139 |
| 62 | PRKD2 | 1.05623945 |
| 63 | MAPK11 | 1.04052681 |
| 64 | PTK2 | 1.00438630 |
| 65 | TAOK3 | 0.96931233 |
| 66 | TEC | 0.96008047 |
| 67 | CSNK1G3 | 0.95991146 |
| 68 | GRK7 | 0.95684026 |
| 69 | STK3 | 0.94822362 |
| 70 | FGFR3 | 0.93624349 |
| 71 | TTN | 0.91787595 |
| 72 | MAP3K12 | 0.91573409 |
| 73 | EIF2AK3 | 0.91127019 |
| 74 | FER | 0.90854965 |
| 75 | PBK | 0.90844829 |
| 76 | STK39 | 0.89921502 |
| 77 | NTRK1 | 0.88142606 |
| 78 | ROCK2 | 0.86735279 |
| 79 | IKBKE | 0.82256577 |
| 80 | TIE1 | 0.80738356 |
| 81 | MOS | 0.79580277 |
| 82 | EPHA3 | 0.79334182 |
| 83 | CDK12 | 0.78601196 |
| 84 | PIK3CG | 0.78554832 |
| 85 | PIK3CA | 0.78224972 |
| 86 | MAPK12 | 0.77288304 |
| 87 | NEK9 | 0.76337577 |
| 88 | PRKCE | 0.75872771 |
| 89 | SGK3 | 0.74061277 |
| 90 | CLK1 | 0.73914276 |
| 91 | MYLK | 0.73161890 |
| 92 | PRKCH | 0.72427656 |
| 93 | MET | 0.71246223 |
| 94 | PRKAA2 | 0.70625948 |
| 95 | PLK2 | 0.69856155 |
| 96 | SIK3 | 0.69392244 |
| 97 | NUAK1 | 0.69225839 |
| 98 | ADRBK1 | 0.68802065 |
| 99 | MARK1 | 0.68385838 |
| 100 | MAP3K7 | 0.66222326 |
| 101 | DMPK | 0.65819080 |
| 102 | CAMK2G | 0.64764757 |
| 103 | MAP3K4 | 0.64712601 |
| 104 | IKBKB | 0.64410267 |
| 105 | ROCK1 | 0.64288862 |
| 106 | EPHB2 | 0.61343149 |
| 107 | TGFBR1 | 0.61162541 |
| 108 | PHKG1 | 0.60593252 |
| 109 | PHKG2 | 0.60593252 |
| 110 | MAP3K1 | 0.59328487 |
| 111 | GSK3A | 0.59080847 |
| 112 | OBSCN | 0.58684356 |
| 113 | WNK1 | 0.58651433 |
| 114 | NTRK2 | 0.58161473 |
| 115 | CAMK2B | 0.56163478 |
| 116 | PRKG2 | 0.56046489 |
| 117 | BRD4 | 0.54065062 |
| 118 | CAMK2D | 0.53298398 |
| 119 | CAMK2A | 0.51893895 |
| 120 | PRKACA | 0.51590188 |
| 121 | DYRK3 | 0.51193320 |
| 122 | CDK8 | 0.50736782 |
| 123 | DYRK2 | 0.49943764 |
| 124 | MAPK7 | 0.49811401 |
| 125 | MTOR | 0.49604710 |
| 126 | FES | 0.49243738 |
| 127 | MAPK4 | 0.49120458 |
| 128 | CDK5 | 0.48088913 |
| 129 | OXSR1 | 0.48069363 |
| 130 | RPS6KA4 | 0.47942659 |
| 131 | ACVR1B | 0.47853125 |
| 132 | RIPK1 | 0.47738236 |
| 133 | KSR2 | 0.46959367 |
| 134 | BLK | 0.46636806 |
| 135 | PRKCZ | 0.45966460 |
| 136 | CAMK1 | 0.45779248 |
| 137 | DYRK1A | 0.45558040 |
| 138 | UHMK1 | 0.45176485 |
| 139 | TGFBR2 | 0.44394427 |
| 140 | BRSK2 | 0.43717828 |
| 141 | PLK4 | 0.43663570 |
| 142 | MAP2K1 | 0.43533637 |
| 143 | MAP2K6 | 0.42982370 |
| 144 | HIPK2 | 0.42424326 |
| 145 | EPHA4 | 0.41063452 |
| 146 | STK38 | 0.40151706 |
| 147 | STK24 | 0.39564435 |
| 148 | CSNK1G1 | 0.39415731 |
| 149 | PRKG1 | 0.39271201 |
| 150 | WNK4 | 0.37612835 |
| 151 | SIK1 | 0.35943657 |
| 152 | GRK5 | 0.35467895 |
| 153 | PRKCQ | 0.34575097 |
| 154 | FGFR4 | 0.34156987 |
| 155 | RPS6KB1 | 0.33470382 |
| 156 | BRAF | 0.32988291 |
| 157 | MAPKAPK5 | 0.32716153 |
| 158 | VRK1 | 0.32225749 |
| 159 | CAMK4 | 0.28513634 |
| 160 | PRKCG | 0.27927705 |
| 161 | PRKCA | 0.26840968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.75365916 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.64857292 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.54848538 |
| 4 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.53849096 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.33556097 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.33278397 |
| 7 | Peroxisome_Homo sapiens_hsa04146 | 2.32844559 |
| 8 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.28569501 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.26265861 |
| 10 | Retinol metabolism_Homo sapiens_hsa00830 | 2.22416907 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20184105 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.16674683 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.11582336 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.06364653 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.01476419 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00330442 |
| 17 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.98939964 |
| 18 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.97849231 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.93140799 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.87981762 |
| 21 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.86658426 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86159213 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83456824 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.82165166 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.72626288 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.72585257 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.72115411 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.65445663 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.61244620 |
| 30 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.60361316 |
| 31 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.56983526 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.56324953 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.54870526 |
| 34 | Renin secretion_Homo sapiens_hsa04924 | 1.53307308 |
| 35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.52982466 |
| 36 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.50784098 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.49830898 |
| 38 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.44548246 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.43836673 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.42927780 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.42516391 |
| 42 | Melanogenesis_Homo sapiens_hsa04916 | 1.41555254 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.41013267 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.39304281 |
| 45 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.36818223 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.33285277 |
| 47 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.31039086 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29750106 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.28077510 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.27344665 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.27244526 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.26695754 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.25741503 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.24068582 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22353699 |
| 56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.21643916 |
| 57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.20602451 |
| 58 | Focal adhesion_Homo sapiens_hsa04510 | 1.20456023 |
| 59 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.18880599 |
| 60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18432435 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16281987 |
| 62 | Circadian entrainment_Homo sapiens_hsa04713 | 1.15561163 |
| 63 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.14993220 |
| 64 | Adherens junction_Homo sapiens_hsa04520 | 1.11616777 |
| 65 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.11397345 |
| 66 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.08189056 |
| 67 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.05123678 |
| 68 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.04239065 |
| 69 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.03870413 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.03732534 |
| 71 | Protein export_Homo sapiens_hsa03060 | 1.03595353 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.02263833 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02235310 |
| 74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.00838095 |
| 75 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.00064307 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99079298 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.98802453 |
| 78 | Melanoma_Homo sapiens_hsa05218 | 0.98057325 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.97142030 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.96580414 |
| 81 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95971958 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95624447 |
| 83 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.95188887 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.92776915 |
| 85 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.92534795 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92493067 |
| 87 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.92336911 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.91690393 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91223459 |
| 90 | Gap junction_Homo sapiens_hsa04540 | 0.89237051 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.88092367 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.87025182 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.86249354 |
| 94 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.85365774 |
| 95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.83722267 |
| 96 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.83668080 |
| 97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.83099170 |
| 98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.82951214 |
| 99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.82536262 |
| 100 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.81066989 |
| 101 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.80405749 |
| 102 | Cocaine addiction_Homo sapiens_hsa05030 | 0.79854386 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79217040 |
| 104 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77313928 |
| 105 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76625801 |
| 106 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.76615890 |
| 107 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.76532565 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74651099 |
| 109 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.72524706 |
| 110 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.72120900 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.71796037 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.71391794 |
| 113 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71350399 |
| 114 | Long-term potentiation_Homo sapiens_hsa04720 | 0.70850188 |
| 115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70641201 |
| 116 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.70177996 |
| 117 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.68818181 |
| 118 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.68127919 |
| 119 | Taste transduction_Homo sapiens_hsa04742 | 0.67944054 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67890495 |
| 121 | Huntingtons disease_Homo sapiens_hsa05016 | 0.67251926 |
| 122 | GABAergic synapse_Homo sapiens_hsa04727 | 0.66425120 |
| 123 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65220250 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65203797 |
| 125 | Long-term depression_Homo sapiens_hsa04730 | 0.64715279 |
| 126 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64256790 |
| 127 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63128764 |
| 128 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62039929 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61462519 |
| 130 | Glioma_Homo sapiens_hsa05214 | 0.60815482 |
| 131 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.60491657 |
| 132 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.59603137 |
| 133 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59452397 |
| 134 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59056090 |
| 135 | Tight junction_Homo sapiens_hsa04530 | 0.58929587 |
| 136 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58365689 |
| 137 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57962740 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54137689 |
| 139 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53553777 |
| 140 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.53459528 |
| 141 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.53388036 |
| 142 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50192539 |
| 143 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49304799 |
| 144 | Nicotine addiction_Homo sapiens_hsa05033 | 0.48878702 |
| 145 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48260927 |
| 146 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.44727064 |
| 147 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40748338 |
| 148 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39414402 |
| 149 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39029497 |
| 150 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.38613695 |
| 151 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.38425591 |
| 152 | Morphine addiction_Homo sapiens_hsa05032 | 0.35971941 |
| 153 | Purine metabolism_Homo sapiens_hsa00230 | 0.35094591 |
| 154 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33103855 |
| 155 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.29945876 |
| 156 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29599488 |
| 157 | Lysine degradation_Homo sapiens_hsa00310 | 0.27376808 |
| 158 | Basal transcription factors_Homo sapiens_hsa03022 | 0.26831013 |
| 159 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.26125605 |
| 160 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.25715442 |
| 161 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.24342112 |
| 162 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24316924 |
| 163 | Allograft rejection_Homo sapiens_hsa05330 | 0.24274755 |
| 164 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.24167677 |

